Biofrontera Inc. (NASDAQ: BFRI) is a biopharmaceutical company focused on the commercialization of dermatological therapies and treatments for skin conditions. The company’s portfolio includes products designed to address actinic keratosis and other dermatologic indications through innovative therapeutic approaches and physician-focused commercialization efforts.

Topics discussed include the company’s commercial operations, business strategy, growth initiatives, market opportunities, and long-term outlook.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.